QA: Neurotrope Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001513856_2019_Neurotrope_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001513856, Neurotrope Inc

  xvar xval
0 AssetsCurrent 29,457,542
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 20,842
3 remainder_Assets 0
4 LiabilitiesCurrent 2,957,075
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,030,175
9 ResearchAndDevelopmentExpense 4,627,055
10 remainder_Expenses 2,569,947
11 remainder_Revenues 0
12 remainder_NetIncome 169,002
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 29,478,384
1 Liabilities 2,957,075
2 Expenses 11,227,177
3 Revenues 0
4 StockholdersEquity 26,521,309
5 NetIncome -11,058,175
6 ComprehensiveNetIncome -11,058,175
7 BaseVar 21,915,819
8 EconomicCapitalRatiobeforeLimitedLiability 2.88
9 EconomicCapitalRatio 3.61

Edgar->Model Mapping

Feature Distribution

Change over Time